APVO - Aptevo Therapeutics - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

APVO is currently covered by 1 analysts with an average price target of $16.94. This is a potential upside of $16.23 (2285.92%) from yesterday's end of day stock price of $0.71.

Aptevo Therapeutics's activity chart (see below) currently has 12 price targets and 13 ratings on display. The stock rating distribution of APVO is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 10% with an average time for these price targets to be met of 65.5 days.

Highest price target for APVO is $5, Lowest price target is $4, average price target is $16.94.

Most recent stock forecast was given by EDWARD TENTHOFF from PIPER SANDLER on 12-Aug-2022. First documented stock forecast 05-Oct-2017.

Best performing analysts who are covering APVO - Aptevo Therapeutics:

Edward Tenthoff Jonathan Aschoff

Currently out of the existing stock ratings of APVO, 2 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

13

$11.97 (1162.14%)

20

1 years 9 months 14 days ago

2/10 (20%)

$8.58 (194.12%)

131

Buy

50

2 years 6 months 14 days ago

0/2 (0%)

$23.88 (91.42%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is APVO (Aptevo Therapeutics) average time for price targets to be met?

On average it took 65.5 days on average for the stock forecasts to be realized with a an average price target met ratio 10

Which analyst has the current highest performing score on APVO (Aptevo Therapeutics) with a proven track record?

EDWARD TENTHOFF

Which analyst has the current lower performing score on APVO (Aptevo Therapeutics) with a proven track record?

JONATHAN ASCHOFF

Which analyst has the most public recommendations on APVO (Aptevo Therapeutics)?

Edward Tenthoff works at PIPER SANDLER and has 7 price targets and 6 ratings on APVO

Which analyst is the currently most bullish on APVO (Aptevo Therapeutics)?

Edward Tenthoff with highest potential upside - $11.97

Which analyst is the currently most reserved on APVO (Aptevo Therapeutics)?

Jonathan Aschoff with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?